{
 "ticker": "TDNA",
 "name": "T. Rowe Price Biotech ETF",
 "issuer": "T. Rowe Price",
 "desk": "themes",
 "url": "https://etfiq.com/funds/tdna",
 "html": "https://etfiq.com/funds/tdna",
 "markdown": "https://etfiq.com/funds/tdna.md",
 "as_of": "2026-10-02",
 "verdict": "TDNA has not filed its holdings yet, so there is nothing to look through.",
 "key_facts": [
  {
   "key": "total_return_since_launch",
   "label": "Total return, since launch",
   "value": "\u22123.6%",
   "source": null,
   "as_of": "2026-10-02",
   "sentence": "TDNA, total return, since launch: \u22123.6%, as of Oct 2, 2026."
  },
  {
   "key": "expense_ratio",
   "label": "Expense ratio",
   "value": "0.55%",
   "source": "485BPOS XBRL, Jul 24, 2026",
   "as_of": "2026-10-02",
   "sentence": "TDNA, expense ratio: 0.55% (485BPOS XBRL, Jul 24, 2026)."
  }
 ],
 "fields": [
  {
   "key": "theme",
   "label": "Theme",
   "value": "Biotech",
   "source": "ETFIQ, editorial"
  },
  {
   "key": "launched",
   "label": "Launched",
   "value": "Sep 17, 2026",
   "source": null
  },
  {
   "key": "below_its_all_time_high",
   "label": "Below its all-time high",
   "value": "\u22124.0%",
   "source": "ETFIQ"
  },
  {
   "key": "expense_ratio",
   "label": "Expense ratio",
   "value": "0.55%",
   "source": "485BPOS XBRL, Jul 24, 2026"
  }
 ],
 "periods": [
  {
   "window": "Since launch",
   "Total return": "\u22123.6%",
   "S&P 500": "+1.2%",
   "Gap to S&P 500": "\u22124.8 pts",
   "Gap to Nasdaq-100": "\u22128.3 pts"
  }
 ],
 "questions": [
  {
   "q": "Has TDNA beaten the S&P 500?",
   "a": "Over the year to Oct 2, 2026 TDNA returned \u22123.6% with distributions reinvested, against +1.2% for the S&P 500, so it finished behind the index by 4.8 points."
  },
  {
   "q": "What does TDNA cost?",
   "a": "The prospectus expense ratio is 0.55% a year."
  }
 ],
 "generated": "2026-10-03",
 "license": "https://etfiq.com/license/",
 "license_text": "Free to use with attribution. ETFIQ (etfiq.com)."
}